Medtronic, Dell and 3 Stocks to Watch Heading Into Tuesday

Ahead of earnings, Wall Street is looking for Medtronic to report EPS of $1.39 on $9.54B revenue, while Dell is expected at $4.91 EPS on $44.95B revenue and Palo Alto Networks at $0.98 EPS on $3.35B revenue. Recent prints show Pyxis Tankers beating expectations (27c vs 20c; $12.134M vs $11.380M) with shares up 12.9%, while Cango delivered downbeat results and fell 8.4%. Net effect is mixed near-term stock-specific momentum rather than a broad market catalyst.

Analysis

The tape is likely to keep rewarding only the names where the print changes the next 1-3 month estimate, not the ones that merely clear a low bar. That favors DELL and PANW as event-driven volatility candidates, but the key variable is forward demand quality: for DELL, AI server mix and cash conversion matter more than earnings; for PANW, billings/RPO and guide will dominate the headline EPS print and can swing the multiple more than the quarter itself.

MDT reads as a defensive confirmation trade rather than a growth rerating. A stable print would mostly support a lower-volatility relative-value bid versus more cyclical med-tech, while any procedural softness would matter less immediately than whether management is signaling that the underlying surgery cycle is still healing. CANG is the weakest setup because microcap China exposure turns a mild miss into a funding/liquidity problem; the second-order risk is not just lower valuation, but tighter access to capital if the ADR remains under pressure.

PXS is the most purely tactical name: small-cap tanker beats can overshoot because positioning is thin and spot-rate expectations are reflexive. The contrarian point is that a good quarter does not necessarily change the medium-term earnings power if freight rates flatten, so chasing the gap without confirmation on rate data is low quality. In this basket, the consensus may be overfocusing on EPS and underweighting forward bookings, cash burn, and balance-sheet optionality.

Key Decisions for Investors

• DELL: trade only on confirmation, not the initial pop. Buy the post-print dip if AI server revenue and FY free-cash-flow guide are intact; target a 8-12% rerating over 1-2 months, stop if gross margin or capex intensity deteriorates.
• PXS: tactically long for 1-3 trading sessions only, then trim into strength. Low-float shipping names can gap 15-20% on a beat, but the move fades quickly if spot tanker rates do not confirm.
• CANG: avoid owning the bounce; if borrow/liquidity allow, short any retracement toward the pre-earnings range. Thesis is funding/risk of dilution over 1-3 months; falsify only if management shows a clear path to cash-flow breakeven.
• MDT: consider a small relative-value long versus a higher-beta med-tech basket or IHI if management signals stable procedure trends. Upside is modest, but downside is limited if the print confirms demand resilience.
• PANW: no pre-print directional trade unless you have a strong view on billings. Watch for guide/RPO; a weak forward number can compress the multiple 10-15% even with an EPS beat.